Health
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies. Demand for […]
Read More
Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots
Independent Presidential candidate Robert F. Kennedy Jr. speaks during a campaign rally at Legends Event Center on December 20, 2023 in Phoenix, Arizona. Rebecca Noble | Getty Images The Supreme Court on Monday turned away two Covid-related appeals brought by Children’s Health Defense, the anti-vaccine group founded by independent presidential candidate Robert F. Kennedy Jr. The decision […]
Read More
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year. If cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called obstructive […]
Read More
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers
The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking. The FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently acquired by tobacco giant Altria, which also sells Marlboro cigarettes. The decision lends new […]
Read More
Neuralink competitor Paradromics gears up to test its brain implant on humans
Neurotech start-up Paradromics will be trialing its brain implant next year, as the race to be the leader in the nascent brain-computer interface (BCI) space heats up. “The brain is a super fascinating organ. We have about 85 billion neurons and every neuron is a million times slower than a computer chip. And yet, the […]
Read More
Catalyst calendar: Here’s a look at major events that could propel these 7 stocks higher
AI tech stocks have been on the rage on Wall Street. But here are some events that could lift other Club names higher in the weeks and months ahead. Source
Read More
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable weight loss medication Wegovy at New City Halstead Pharmacy in Chicago on April 24, 2024. Scott Olson | Getty Images Good morning! More U.S. employers are covering a buzzy class of medications called GLP-1s for weight […]
Read More
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said. Merck’s shot, called Capvaxive, specifically protects against 21 strains […]
Read More
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. George Frey | Bloomberg | Getty Images Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new heights over the last year. […]
Read More
The 4 key things we’re watching in the stock market this holiday-shortened week
The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new data this past week showed a continued cooling of inflation and Treasury yields retreated. For the week: The tech-heavy Nasdaq gained 3.2%, while the S & P 500 rose 1.6% and the Dow Jones Industrial Average fell 0.5%. Economic updates […]
Read More